Ageing and cancer are both associated with the accumulation of mutations in DNA [ 66 ], and, among other changes, ageing affects the hematopoietic clonal heterogeneity (designated either as ARCH for age‐related clonal haematopoiesis or as CHIP for clonal haematopoiesis of indeterminate significance).
1
—
—